What are the recommended injection sites for fillers, such as hyaluronic acid (Restylane, Juvederm) or calcium hydroxylapatite (Radiesse), in a healthy adult, likely in their 40s or older, experiencing typical signs of natural aging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Filler Injection Sites for Natural Aging

For natural aging in adults 40+, inject fillers into the tear troughs, nasolabial folds, jawline, lips, and perioral wrinkles using intradermal placement with 30-gauge needles at shallow angles to target volume loss and fine lines while avoiding deep vascular structures. 1, 2

Primary Injection Sites Based on Aging Patterns

Tear Trough Area

  • The tear trough is a validated injection site for addressing hollowing and aging appearance, with significant clinical improvement demonstrated on the Tear Trough Rating Scale at 3-month follow-up 1
  • Inject using intradermal technique to avoid the deep hypodermis where major vessels like the transverse facial artery reside 2
  • Both hyaluronic acid and calcium hydroxylapatite show efficacy, with mean duration of 10.1 months for HA and 12.8 months for calcium hydroxylapatite 3

Nasolabial Folds

  • Nasolabial folds are among the most common injection sites for facial aging, particularly for patients scoring 1-2 on the Merz 5-point scale 4, 5
  • A mixture of 1.5 mL calcium hydroxylapatite with 1.0 mL hyaluronic acid maintains constant volume with high satisfaction scores, as the HA compensates for early volume loss of calcium hydroxylapatite 4
  • Consider intraoral approach for deep nasolabial folds to minimize risk of intravascular injection and associated complications like skin necrosis 6

Jawline and Lower Face

  • The jawline is an established injection site for addressing age-related volume loss and contour deficiency 4
  • Use 3.0 mL total volume of mixed fillers for combined nasolabial fold and jawline treatment 4

Perioral Region and Lips

  • Facial wrinkles and fine lines around the mouth respond well to filler injection, with Wrinkle Severity Rating Scale scores decreasing from baseline 3.18 to 1.65 at 3 months 1
  • Crow's feet and perioral rhytides show significant improvement post-injection (p<0.001) 1
  • Lip injections using 0.5 mL per quadrant (2 mL total) demonstrate significant rejuvenation at 3-month follow-up 1

Additional Sites for Comprehensive Rejuvenation

  • Face, neck, and hands are all appropriate sites for volumizing and contouring fillers 1
  • These areas benefit from both traditional fillers and autologous platelet concentrate bio-fillers 1

Critical Safety Protocol for All Injection Sites

Injection Depth and Technique

  • Use intradermal placement exclusively with 30-gauge, 4mm needles inserted at shallow angles with bevel facing upward 2
  • Create visible papules or wheals with blanching during injection to confirm proper intradermal placement and avoid deep vasculature 2
  • Aspirate the needle prior to each injection to detect intravascular placement before filler administration 2

Volume and Distribution

  • Use incremental injections rather than large boluses to minimize vascular compression and allow early detection of complications 2
  • For nasolabial folds and jawline: 3.0 mL total volume is appropriate 4
  • For tear troughs: individualized volume based on severity, typically 0.5-1.0 mL per side 1

Filler Selection by Site

Hyaluronic Acid (Restylane, Juvederm)

  • HA fillers are appropriate for all facial sites with duration of approximately 10.1 months for tear troughs 3
  • Can be mixed 1:1 with calcium hydroxylapatite for enhanced longevity and reduced early volume loss 4

Calcium Hydroxylapatite (Radiesse)

  • Provides longer-lasting results with mean duration of 12.8 months for tear troughs 3
  • Best used in mixture with HA (1.5 mL calcium hydroxylapatite + 1.0 mL HA + 0.5 mL lidocaine) to prevent unexpected early volume loss before neocollagenesis occurs 4

Autologous Platelet Concentrates (Bio-Filler)

  • Consider APCs as a safer alternative when volumization is not the primary goal, particularly for fine lines and overall rejuvenation rather than structural volumization 2
  • Appropriate for tear troughs, crow's feet, facial wrinkles, and perioral areas with effects lasting 4-6 months 1
  • Lower risk of vascular occlusion complications compared to traditional fillers 1

Common Pitfalls to Avoid

  • Never inject deep into the hypodermis where major vessels like the facial and transverse facial arteries reside 2
  • Avoid areas with scars, bony prominences, or previous complications 2
  • Do not use permanent fillers except in reconstructive procedures due to high complication rates requiring surgical correction 7
  • Ensure adequate training in facial anatomy and injection techniques before performing procedures 5
  • Document all treatments and obtain detailed informed consent including filler type, expected longevity, and possible complications 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Local Anesthetic Injection Techniques

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Improvement of tear trough by monophasic hyaluronic Acid and calcium hydroxylapatite.

The Journal of clinical and aesthetic dermatology, 2014

Research

Standard guidelines for the use of dermal fillers.

Indian journal of dermatology, venereology and leprology, 2008

Research

Surgery for foreign body reactions due to injectable fillers.

Dermatology (Basel, Switzerland), 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.